205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.36%
Revenue growth 1.25-1.5x NXPI's 8.27%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
17.05%
Gross profit growth above 1.5x NXPI's 9.06%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
41.52%
EBIT growth 1.25-1.5x NXPI's 36.07%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
42.32%
Operating income growth 1.25-1.5x NXPI's 36.07%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
40.25%
Net income growth comparable to NXPI's 44.55%. Walter Schloss might see both following similar market or cost trajectories.
43.18%
EPS growth similar to NXPI's 46.67%. Walter Schloss would assume both have parallel share structures and profit trends.
40.91%
Diluted EPS growth at 75-90% of NXPI's 48.84%. Bill Ackman would expect further improvements in net income or share count reduction.
-0.93%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.91%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.31%
Dividend growth of 0.31% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
67.75%
Positive OCF growth while NXPI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
80.52%
Positive FCF growth while NXPI is negative. John Neff would see a strong competitive edge in net cash generation.
67.30%
10Y revenue/share CAGR above 1.5x NXPI's 34.07%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
58.50%
5Y revenue/share CAGR above 1.5x NXPI's 34.07%. David Dodd would look for consistent product or market expansions fueling outperformance.
2.76%
3Y revenue/share CAGR under 50% of NXPI's 25.41%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
152.27%
10Y OCF/share CAGR in line with NXPI's 162.23%. Walter Schloss would see both as similarly efficient over the decade.
64.60%
Below 50% of NXPI's 162.23%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
32.57%
3Y OCF/share CAGR under 50% of NXPI's 1301.09%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
155.09%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
210.77%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
9.70%
Below 50% of NXPI's 97.26%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
38.59%
Equity/share CAGR of 38.59% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
34.39%
Equity/share CAGR of 34.39% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
3.61%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
1337.84%
Dividend/share CAGR of 1337.84% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
174.90%
Dividend/share CAGR of 174.90% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
132.42%
3Y dividend/share CAGR of 132.42% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.69%
AR growth well above NXPI's 13.39%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.75%
Inventory growth well above NXPI's 1.49%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-5.94%
Negative asset growth while NXPI invests at 0.11%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.53%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-17.76%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.64%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.46%
We cut SG&A while NXPI invests at 1.41%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.